Stocks and Investing Stocks and Investing
Wed, February 1, 2023

Evan David Seigerman Maintained (AMGN) at Hold with Decreased Target to $253 on, Feb 1st, 2023


Published on 2024-10-28 01:15:14 - WOPRAI, Evan David Seigerman
  Print publication without navigation


Evan David Seigerman of BMO Capital, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $276 to $253 on, Feb 1st, 2023.

Evan has made no other calls on AMGN in the last 4 months.



There are 3 other peers that have a rating on AMGN. Out of the 3 peers that are also analyzing AMGN, 1 agrees with Evan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Risinger of "SVB Leerink" Maintained at Hold with Increased Target to $282 on, Thursday, December 22nd, 2022


These are the ratings of the 2 analyists that currently disagree with Evan


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $293 on, Thursday, January 19th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022

Contributing Sources